Previous Close | 230.21 |
Open | 232.62 |
Bid | 96.14 x 900 |
Ask | 259.99 x 1100 |
Day's Range | 231.69 - 244.41 |
52 Week Range | 217.20 - 460.21 |
Volume | |
Avg. Volume | 557,128 |
Market Cap | 12.417B |
Beta (5Y Monthly) | 1.27 |
PE Ratio (TTM) | 29.79 |
EPS (TTM) | 8.20 |
Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 332.18 |
Subscribe to Yahoo Finance Plus to view Fair Value for CRL
In this article, we discuss the 10 biggest losers in Gabriel Plotkin’s Melvin Capital portfolio. If you want to see more holdings that dropped in value, click 5 Biggest Losers in Gabriel Plotkin’s Melvin Capital Portfolio. Reddit investors made it their mission to bludgeon Gabriel Plotkin’s Melvin Capital in their battle with the hedge fund […]
The contract research organization is adding a 200,000-square-foot expansion to increase capacity for client work and enhance employees' experience.
Does the May share price for Charles River Laboratories International, Inc. ( NYSE:CRL ) reflect what it's really...